China’s Sinovac COVID-19 vaccine has been approved for use in adults 18 years and older.
There is a new clinical trial underway to assess the safety and effectiveness of mixing different types of booster shots in adults who have been fully vaccinated against COVID-19.
Some prison systems in the United States have been able to vaccinate high numbers of inmates against COVID-19, and that success could point to ways to convince skeptical people in the general public to get vaccinated.
The median PFS was 8.5 months in the pasireotide arm, 12.5 months in the everolimus arm, and 16.5 months in the combination arm.
The cause of rare blood clots in some people who have received the AstraZeneca and Johnson & Johnson COVID-19 vaccines has been found.
COVID-19 symptoms frequently persist beyond the acute phase of infection.
Although considerable progress has been observed in countries around the world in reducing the prevalence of smoking tobacco use, a large implementation gap remains with respect to tobacco control.
Patients with immune-mediated inflammatory diseases receiving background methotrexate have worse humoral and cellular immunogenicity to mRNA COVID-19 vaccines.
Health care workers are more likely to test positive with SARS-CoV-2 infection, and the risk for reinfection is low.
COVID-19 vaccines may provide protection for at least a year, and possibly even a lifetime, to people who were previously exposed to the virus.
The USPSTF recommends behavioral counseling interventions to promote healthy weight gain in pregnancy.